Novo Nordisk is also making moves: Health Canada approved Plosbrio and Poviztra in December 2025 Novo's own renamed copies of Ozempic and Wegovy
References: Glucagon-like peptide-1 receptor activation and mental health: a drug-target mendelian randomization study - ( Psychotropic effects of GLP-1R agonists - ( The Impact of GLP-1 Receptor Agonists (GLP-1 RAs) on Mental Health: A Systematic Review - ( The Antidepressant Effects of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis - ( India: Doctors report surge in use of off label GLP-1 agonists among rich - (
Graaf Cd, Donnelly D, Wootten D, et al
Symptoms You Should Know About Mild effects often go away, but some symptoms might need a doctors attention
In reproductive immunology, uterine NK cells play essential roles in early pregnancy tolerance through killer cell immunoglobulin-like receptors (Male and Moffett, 2023)
In a six-month clinical trial, a GLP-1 drug called liraglutide was shown to slow the progression of the disease and improve the cerebral metabolic rate of glucose (CMRglc), which is a measurement of glucose metabolism in the brain important for normal cognitive function